VANCOUVER, BC— Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (“Mind Cure” or the “Corporation”) is pleased today to announce the hiring of Dr. Ryan Hartwell as the company’s Chief Science Officer. A trusted and respected leader in the life sciences community, Dr. Hartwell is also a successful entrepreneur and inventor with extensive regulatory experience in new drug and natural health product research and development. With a rigorous clinical research approach, Dr. Hartwell will lead all scientific efforts at Mind Cure alongside the company’s scientific advisory board.
“We have assembled a team of exceptional scientific advisors, and Dr. Hartwell is the perfect person to both lead them and guide our overall scientific efforts as we find new ways to treat mental health,” said Philip Tapley, Mind Cure Chairman, President, and CEO. “Dr. Hartwell will be integral to our goal of bringing new psychoactive and psychedelic drugs, treatments and technologies to market, with proper research and scientific validation.”
Dr. Hartwell has served on Mind Cure’s scientific advisory board for several months and is looking forward to the opportunity to further establish Mind Cure as a leader in the mental health revolution through research and science. “After a decade of researching solutions to prevent and treat physical scars, I am thrilled to join Mind Cure and the world-class team of scientists and researchers working towards a cure for psychological scarring,” said Dr. Ryan Hartwell. “From all that we have learned in studying psychedelics, the opportunity to chart a new path toward a better understanding and discovery of effective medicines provides tremendous potential to transform mental health and aging wellness.”
Dr. Hartwell will serve a key role in the advancement of Mind Cure’s science-first approach to research and product development and will lead the company’s efforts to explore a range of new psychoactive and psychedelic substances and their therapeutic benefits. Mind Cure is focused on developing safe and effective new drugs and treatments and bringing them to market with proper scientific validation and medical and regulatory compliance.
